Eli Lilly shares surged more than 7% on Thursday after the pharmaceutical giant raised its annual sales and profit forecast, driven by soaring demand for its obesity treatments. The company reported that thousands of patients had started taking its new weight-loss pill even before any advertising began. The stock posted its biggest single-day gain since February.
Meanwhile, Caterpillar jumped about 9% in morning trading after reporting better-than-expected quarterly earnings. The industrial heavyweight also lifted its long-term revenue outlook, citing robust sales of construction and power generation equipment.
Royal Caribbean also rose, contributing to a positive day for the broader market.
The moves underscore a broader trend of investors betting on companies with strong growth catalysts, from healthcare innovation to infrastructure spending.